Trials / Unknown
UnknownNCT01287806
Ulinastatin in Inhalation Lung Injury
Multicenter,Randomized,Parallel Assignment,Blank Control Study of Ulinastatin in Inhalation Lung Injury
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and effect of ulinastatin in inhalation lung injury patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ulinastatin | Resolved 4 vials of drugs in 100ml physiological saline solution,intravenously infused for 1-2h,tid,for continuous 10days |
| DRUG | blank group | standard treatment |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-12-01
- Completion
- 2013-01-01
- First posted
- 2011-02-01
- Last updated
- 2011-02-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01287806. Inclusion in this directory is not an endorsement.